TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Novonesis Plant Biosolutions A/S
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
15,093
|
19,997,929
|
17,930 |
Earnings before taxes |
52,664
|
44,776
|
19,812 |
Total assets |
130,489
|
137,658,116
|
110,686 |
Current assets |
106,427
|
103,817,790
|
66,157 |
Current liabilities |
26,464
|
26,133
|
20,582 |
Equity capital |
97,851
|
110,525,369
|
85,720 |
- share capital |
81
|
80,766
|
81 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
75.0%
|
80.3%
|
77.4% |
Turnover per employee | |||
Profit as a percentage of turnover |
348.9%
|
0.2%
|
110.5% |
Return on assets (ROA) | |||
Current ratio |
402.2%
|
397267.0%
|
321.4% |
Return on equity (ROE) |
53.8%
|
0.0%
|
23.1% |
Change turnover |
-19,938,294
|
19,979,999
|
-2,164 |
Change turnover % |
-100%
|
111432%
|
-11% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.